A citation-based method for searching scientific literature

Mary Jo Lund, Katrina F Trivers, Peggy L Porter, Ralph J Coates, Brian Leyland-Jones, Otis W Brawley, Elaine W Flagg, Ruth M O'Regan, Sheryl G A Gabram, J William Eley. Breast Cancer Res Treat 2009
Times Cited: 278



Rowan T Chlebowski, Zhao Chen, Garnet L Anderson, Thomas Rohan, Aaron Aragaki, Dorothy Lane, Nancy C Dolan, Electra D Paskett, Anne McTiernan, F Alan Hubbell, Lucile L Adams-Campbell, Ross Prentice. J Natl Cancer Inst 2005
Times Cited: 444




List of shared articles



Times cited

Clinical Outcomes and Immune Markers by Race in a Phase I/II Clinical Trial of Durvalumab Concomitant with Neoadjuvant Chemotherapy in Early-Stage TNBC.
Julia Foldi, Adriana Kahn, Andrea Silber, Tao Qing, Emily Reisenbichler, Neal Fischbach, Justin Persico, Kerin Adelson, Anamika Katoch, Anees Chagpar,[...]. Clin Cancer Res 2022
0

Differences in Breast Cancer Presentation at Time of Diagnosis for Black and White Women in High Resource Settings.
Jo-Ann Osei-Twum, Sahra Gedleh, Aisha Lofters, Onye Nnorom. J Immigr Minor Health 2021
1

Risk Stratification Model for Predicting the Overall Survival of Elderly Triple-Negative Breast Cancer Patients: A Population-Based Study.
Xiaozhu Liu, Song Yue, Haodong Huang, Minjie Duan, Binyi Zhao, Jin Liu, Tianyu Xiang. Front Med (Lausanne) 2021
3

Genomic analysis of racial differences in triple negative breast cancer.
Chang-Sheng Chang, Eiko Kitamura, Joan Johnson, Roni Bollag, Lesleyann Hawthorn. Genomics 2019
13

Atypical Chemokine Receptor 1 (DARC/ACKR1) in Breast Tumors Is Associated with Survival, Circulating Chemokines, Tumor-Infiltrating Immune Cells, and African Ancestry.
Brittany D Jenkins, Rachel N Martini, Rupali Hire, Andrea Brown, Briana Bennett, I'nasia Brown, Elizabeth W Howerth, Mary Egan, Jamie Hodgson, Clayton Yates,[...]. Cancer Epidemiol Biomarkers Prev 2019
21

Examining Mammography Use by Breast Cancer Risk, Race, Nativity, and Socioeconomic Status.
Bilikisu R Elewonibi, Amy D Thierry, Patricia Y Miranda. J Immigr Minor Health 2018
16

Triple-Negative Breast Cancer, Stem Cells, and African Ancestry.
Evelyn Jiagge, Dhananjay Chitale, Lisa A Newman. Am J Pathol 2018
25


Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians.
Foluso O Ademuyiwa, Yu Tao, Jingqin Luo, Katherine Weilbaecher, Cynthia X Ma. Breast Cancer Res Treat 2017
43

Assessing the Racial and Ethnic Disparities in Breast Cancer Mortality in the United States.
Clement G Yedjou, Paul B Tchounwou, Marinelle Payton, Lucio Miele, Duber D Fonseca, Leroy Lowe, Richard A Alo. Int J Environ Res Public Health 2017
78

Influence of clinical, societal, and treatment variables on racial differences in ER-/PR- breast cancer survival.
M E Roseland, K Schwartz, J J Ruterbusch, L Lamerato, R Krajenta, J Booza, Michael S Simon. Breast Cancer Res Treat 2017
9

How many diseases is triple negative breast cancer: the protagonism of the immune microenvironment.
Diana P Saraiva, M Guadalupe Cabral, António Jacinto, Sofia Braga. ESMO Open 2017
31